Clinical Trial Update: Low-dose Chemotherapy Combine With Tyrosine Kinase Inhibitor to Treat ph+ Acute Lymphoblastic Leukemia Patients [Phase 4]

View source ↗

Summary

This entry describes a Phase 4 clinical trial evaluating a low-dose chemotherapy regimen combined with a tyrosine kinase inhibitor to treat Philadelphia chromos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• Tyrosine kinase inhibitor (unspecified)

Snippet

Sponsor: Tongji Hospital | Conditions: ph+ Acute Lymphoblastic Leukemia | Phase 4 | Status: UNKNOWN